Unichem Laboratories Limited (BOM:506690)

India · Delayed Price · Currency is INR

321.50

-9.00 (-2.72%)

At close: Mar 4, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals	21.11B	17.85B	13.43B	12.70B	12.35B
Pharmaceuticals Growth	18.25%	32.92%	5.76%	2.81%	11.91%
Total	21.11B	17.85B	13.43B	12.70B	12.35B
Total Growth	18.25%	32.92%	5.76%	2.81%	11.91%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	407.40M	409.80M	322.11M	412.52M	370.66M
India Growth	-0.59%	27.22%	-21.92%	11.29%	26.90%
USA	13.25B	10.86B	7.86B	7.34B	7.08B
USA Growth	22.06%	38.23%	6.98%	3.77%	10.97%
Others	6.98B	6.11B	4.85B	4.72B	4.45B
Others Growth	14.34%	26.02%	2.58%	6.11%	16.34%
Total	20.64B	17.38B	13.02B	12.48B	11.90B
Total Growth	18.81%	33.42%	4.36%	4.88%	13.37%

Source: S&P Global Market Intelligence.